Adv Endo | Director of Third Space Endoscopy @VANewMexico @UNMSOM_GI via @BIDMC_GI @HarvardMed @UtGastro | Guidelines @AGA @ASGE | 🇺🇸🇵🇰🇸🇦🇨🇳
Albuquerque, NM
Joined May 2019
- Tweets84
- Following1.9K
- Followers436
- Likes936
Faisal S Ali retweeted
Article in Press: "American Society for Gastrointestinal Endoscopy guideline on endoscopic management of benign and malignant colonic strictures" by Machicado et al. giejournal.org/article/S0016…
@jorgemachicado @SuchapaAraya @GKochharMD @wasabidoc @Bashar_Qumseya @Cteshima @ThosaniMD
Faisal S Ali retweeted
Performing Endoscopy Safely in Pregnant Patients: Best Practices for the Gastroenterology Team
Lim, et al.
📕 doi.org/10.14309/ajg.0000000…
@Fai5alAli @ErinCiampa @tberzin @MLongMD @JasmohanBajaj
Faisal S Ali retweeted
How I Approach It – Performing Endoscopy Safely in Pregnant Patients: Best Practices for the Gastroenterology Team
Lim, et al.
📕 doi.org/10.14309/ajg.0000000…
@AliFai5al @ErinCiampa @tberzin @MLongMD @JasmohanBajaj
Faisal S Ali retweeted
Common Statistical Errors is a new addition to the stats and methods tutorial series @cochranecollab Evidence Synthesis and Methods #CESM @cochranetrain @RacheRichardson onlinelibrary.wiley.com/doi/…
Faisal S Ali retweeted
➡️HBV reactivation in immunosuppression can kill
➡️Who needs antivirals to prevent HBV flares? 😳
➡️A useful quick reference from our updated @AmerGastroAssn guidelines @AGA_Gastro
@ruben_hernaez
@AliFai5al
@traceyg_md
@NUSMedicine
@Julius__Wilder
pubmed.ncbi.nlm.nih.gov/3986…
Faisal S Ali retweeted
⚠️ Patients on immunosuppressive drugs are at risk of HBV reactivation. Our guideline categorizes patients into risk groups to better manage this. Learn more here: ow.ly/fjbw50UOcfI.
@traceyg_md @Julius__Wilder @ruben_hernaez @DrHuangDQ @AliFai5al
Faisal S Ali retweeted
📢 New guideline: Learn how to prevent and manage hepatitis B reactivation in patients on immunosuppressive drugs. Read more here: ow.ly/PjeV50ULbFT
#HepatitisB #GITwitter
@traceyg_md @Julius__Wilder @ruben_hernaez @DrHuangDQ @AliFai5al
Faisal S Ali retweeted
Is it possible to conduct large randomized surgical clinical trials in a single institution? The answer is yes, say Andrew Vickers and colleagues, reporting their experiences at Memorial Sloan Kettering. @SCTorg @VickersBiostat @MSKCancerCenter @MSKBiostats @BehfarEhdaieMD
Faisal S Ali retweeted
💡 Kyoto criteria can forecast #pancreatic cancer risk in IPMN patients for both the short and long haul! ow.ly/1Naf50UsTbN
Faisal S Ali retweeted
Facilitating GRADE judgements about the inconsistency of effects using a novel visualisation approach
#Education by Murad et al.
#OpenAccess
Link: bit.ly/3N9sRQg
Faisal S Ali retweeted
Enhance your research reporting by effectively using effect sizes and confidence intervals. This cheat sheet provides key components, field-specific benchmarks, and common pitfalls to help you interpret and present your findings with clarity and precision. #DataScience #Statistics #Research #Science
Faisal S Ali retweeted
#globalhealth GI @MGH_GI
Dr Kerry-Ann Penn-Brown: FIRST GASTROENTEROLOGY FELLOW IN JAMAICA at the first GI fellowship program in Jamaica
✅1st @DDWMeeting
✅1st @blackingastro
And now
1st@AmCollegeGastro abstract & meeting!
Dear ACG: THANK YOU♥️
#Jamaica #GITwitter
Faisal S Ali retweeted
At the Focal Point, Liu et al perform "Natural orifice transluminal endoscopic surgery for partial cholecystectomy: first clinical practice (with video)." giejournal.org/article/S0016…
#GITwitter #GIEJournal
Faisal S Ali retweeted
Simple tool implementing Bucher’s method for indirect treatment comparisons in meta-analyses
#Education #OpenAccess by @SamJTingle et al.
Link: bit.ly/4dqblSE
Faisal S Ali retweeted
Narrative review explores how to manage use of DOACs—apixaban, rivaroxaban, edoxaban, and dabigatran—in patients undergoing surgical and nonsurgical procedures to decrease risks of bleeding and thromboembolism. ja.ma/4fIm1hL
Faisal S Ali retweeted
Reports of Randomised Controlled Trials should "Begin and Conclude" with Up-To-Date Systematic Reviews of Other Relevant Trials
doi.org/10.1177/014107682412…
#RCT #SystematicReviews #EvidenceSynthesis
Faisal S Ali retweeted
🚦Essentials for #evidencesynthesis #HTA #guidelines in @bmj_latest ROBVALU: a risk of bias tool for studies of people’s values, utilities or importance of health outcomes bmj.com/content/385/bmj-2024…
@lmbuagbaw @hppardoh @PabloACoello @AStevens_PhD @UweSiebert9 @FengtasticXie
Faisal S Ali retweeted
#GUTImage from the paper by Hamada et al on
"Optimal age to discontinue long-term surveillance of intraductal papillary mucinous neoplasms: comparative cost-effectiveness of surveillance by age" via
bit.ly/3KejI7E
#IPMN
Faisal S Ali retweeted
#DDW2024 pancreatic cyst consortium meeting. Accurate diagnosis (nCLE, NGS), risk-stratification of IPMNs, non-surgical management in pts with high surgical risks - chemoablation, RFA et al.. 🧵with take-home messages
Faisal S Ali retweeted
Big waves 🌊 from small ripples 💧
♻️ Green Endoscopy Initiative: making small changes to have a larger impact 🌏
Honored to be featured in @AGA_GIHN
Big shoutout @iGUT_Houston @MadhavDesaiGI
@UtGastro @AmerGastroAssn @DDWMeeting
#GITwitter #DDW2024
Gastroenterologists at @UTHealthHouston reduced endoscopic waste during colonoscopies by using a single tool instead of multiple disposable tools. We interviewed @PrateekHarne1 about his study, presented at #DDW2024. ow.ly/82aE50ROGez @AlanaPersaudMD @DDWMeeting
